Trials / Completed
CompletedNCT03139292
Comparative Evaluation of Ambu AuraGain Laryngeal Mask and Proseal Laryngeal Mask Airway
Comparative Evaluation of Ambu AuraGain Laryngeal Mask and Proseal Laryngeal Mask Airway in Spontaneously Breathing Patients Undergoing Elective Surgery Under General Anaesthesia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 160 (actual)
- Sponsor
- Tata Main Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Comparison of two different supraglottic airway devices i.e., the ProSeal Laryngeal Mask Airway (PLMA) and Ambu AuraGain, a third generation laryngeal mask Airway.
Detailed description
The study aims to compare the two devices with respect to: Time taken for insertion. Insertion attempts or failed attempt. Oropharyngeal leak pressure Air leak Time taken to pass an orogastric tube Attempts to pass an orogastric tube or failed attempt. Haemodynamic variation Incidence of adverse events like failed insertion, aspiration-regurgitation, hypoxia (SpO2\< 90%), bronchospasm, airway obstruction, gastric insufflation, coughing, gagging, retching, hiccup, coughing during removal, blood staining of the airway device and trauma to tongue, lip, teeth, or gums.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ProSeal Laryngeal Mask Airway | ProSeal Laryngeal Mask Airway was used as the supraglottic device |
| DEVICE | AmbuAuraGain Laryngeal Mask Airway | AmbuAuraGain Laryngeal Mask Airway was used as the supraglottic device |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2019-10-01
- Completion
- 2019-10-01
- First posted
- 2017-05-03
- Last updated
- 2019-12-30
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT03139292. Inclusion in this directory is not an endorsement.